Date Filer Title Filing Type Shares Traded Price Total Held
Dec 01, 2021
Director, President and CEO
Director, President and CEO Form 4 Other acquisition or disposition -- -- 585,191
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Feb 15, 2023
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
May 12, 2022
Director, President and CEO
Director, President and CEO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 50,141 $1.41 538,556
Feb 15, 2023
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 490,000 -- 490,000
Jun 15, 2021
Chief Business Officer
Chief Business Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 400,000 -- 400,000
Jun 01, 2021
Chief Commercial Officer
Chief Commercial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 400,000 -- 400,000
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 150,550 -- 350,203
Aug 23, 2018
Director, Ten Percent Owner
Director, Ten Percent Owner Form 4 Conversion of derivative security 150,550 -- 350,203

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.